SDZNY SANDOZ GROUP AG S/ADR Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
15:42
Aug 09
BarbarianCap Twitter Analyst
Generic fertility drug makers seen as beneficiaries
Buy generic drug makers TEVA, Sandoz (SDZNY), and Hikma (HKMPY) as fertility drug generics see potential demand uplift from increased public awareness around egg freezing; speculative thematic call.
SDZNY 1ST
LOW
10:19
Aug 05
Sandoz biosimilars driving strong growth.
Sandoz is in a golden decade with biosimilars revenue well ahead of 2030 targets, a rapidly expanding pipeline of 36 assets, strong cash generation, and leadership in generics.
SDZNY 1ST
HIGH
11:55
Jul 22
Chloe Meley Reporter, Bloomberg Bloomberg Markets
Trump tariffs threaten generic drug margins
Trump's threat of 100% tariffs on generic drugs could push up costs and squeeze already thin margins, weighing on generic drug makers like Sandoz.
SDZNY 1ST
MED
09:56
Mar 10
Sandoz is making a clear strategic move to capture a large.
Sandoz is making a clear strategic move to capture a large, defined market opportunity as $650B worth of drugs come off patent.
SDZNY
MED

About SDZNY Analyst Coverage

Buzzberg tracks SDZNY (SANDOZ GROUP AG S/ADR) across 3 sources. 2 bullish vs 0 bearish calls from 4 analysts. Sentiment: predominantly bullish (50%). 4 total trade ideas tracked. Latest voices: BarbarianCap, Richard Saynor, Chloe Meley.